Medimaging Integrated Solution Inc. (TPE:6796)
Taiwan · Delayed Price · Currency is TWD 52.00
+1.60 (3.17%)
Sep 18, 2026, 1:30 PM CST
TPE:6796 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 682.01 | 661.39 | 538.92 | 537.15 | 502.09 | 485.87 | |
Revenue Growth | 12.26% | 22.73% | 0.33% | 6.98% | 3.34% | 20.72% |
Cost of Revenue | 414.74 | 381.58 | 304.6 | 229.39 | 247.7 | 230.15 |
Gross Profit | 267.28 | 279.81 | 234.32 | 307.76 | 254.39 | 255.72 |
Selling, General & Admin | 115.98 | 113.44 | 96.05 | 88.29 | 68.57 | 61.53 |
Research & Development | 140.84 | 145.52 | 140.68 | 126.83 | 126.13 | 107.59 |
Operating Expenses | 274.55 | 261.9 | 238.1 | 215.84 | 194.78 | 169.1 |
Operating Income | -7.28 | 17.92 | -3.78 | 91.92 | 59.6 | 86.62 |
Interest Expense | -14.32 | -11.39 | -8.61 | -3.85 | -1.42 | -1.03 |
Interest & Investment Income | 8.04 | 5.8 | 6.06 | 5.08 | 1.41 | 0.36 |
Currency Exchange Gain (Loss) | 26.3 | -8.46 | 13.61 | -2.04 | 26.61 | -5.08 |
Other Non Operating Income (Expenses) | 7.63 | 10.78 | 5.81 | 1.87 | 1.15 | 0.04 |
EBT Excluding Unusual Items | 20.38 | 14.65 | 13.1 | 92.98 | 87.35 | 80.91 |
Gain (Loss) on Sale of Assets | - | - | -0.88 | - | - | - |
Other Unusual Items | 0.02 | - | - | - | 0.06 | - |
Pretax Income | 20.4 | 14.65 | 12.22 | 92.98 | 87.41 | 80.91 |
Income Tax Expense | 6.08 | 6.92 | 6.61 | 18.93 | 17.39 | 14.43 |
Net Income | 14.32 | 7.73 | 5.61 | 74.05 | 70.02 | 66.48 |
Net Income to Common | 14.32 | 7.73 | 5.61 | 74.05 | 70.02 | 66.48 |
Net Income Growth | - | 37.70% | -92.42% | 5.76% | 5.32% | 22.83% |
Shares Outstanding (Basic) | 39 | 38 | 38 | 37 | 35 | 32 |
Shares Outstanding (Diluted) | 39 | 38 | 38 | 37 | 36 | 32 |
Shares Change | 2.37% | -0.09% | 2.40% | 5.14% | 10.01% | 2.10% |
EPS (Basic) | 0.37 | 0.20 | 0.15 | 2.00 | 2.00 | 2.09 |
EPS (Diluted) | 0.37 | 0.20 | 0.15 | 1.98 | 1.96 | 2.05 |
EPS Growth | - | 35.96% | -92.58% | 0.93% | -4.42% | 20.21% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -71.54 | -46.72 | -168.23 | -23.07 | 63.93 | 19.66 |
Free Cash Flow Per Share | -1.83 | -1.22 | -4.39 | -0.62 | 1.80 | 0.61 |
Dividend Per Share | 0.250 | 0.250 | 0.500 | 1.636 | 1.636 | 1.609 |
Dividend Growth | -50.00% | -50.00% | -69.45% | 0% | 1.70% | 39.39% |
Gross Margin | 39.19% | 42.31% | 43.48% | 57.29% | 50.67% | 52.63% |
Operating Margin | -1.07% | 2.71% | -0.70% | 17.11% | 11.87% | 17.83% |
Profit Margin | 2.10% | 1.17% | 1.04% | 13.79% | 13.95% | 13.68% |
Free Cash Flow Margin | -10.49% | -7.06% | -31.22% | -4.29% | 12.73% | 4.05% |
EBITDA | 42.1 | 66.97 | 42.47 | 119.38 | 85.56 | 115.37 |
EBITDA Margin | 6.17% | 10.13% | 7.88% | 22.22% | 17.04% | 23.74% |
D&A For EBITDA | 49.37 | 49.05 | 46.25 | 27.46 | 25.96 | 28.74 |
EBIT | -7.28 | 17.92 | -3.78 | 91.92 | 59.6 | 86.62 |
EBIT Margin | -1.07% | 2.71% | -0.70% | 17.11% | 11.87% | 17.83% |
Effective Tax Rate | 29.79% | 47.26% | 54.08% | 20.36% | 19.90% | 17.83% |